PAUL KYLE: Open Payments
NPI 1437870441 · KAILUA KONA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 26 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $170 |
| Amgen Inc. | 7 | $143 |
| Novo Nordisk Inc | 4 | $97 |
| PFIZER INC. | 3 | $70 |
| Lilly USA, LLC | 1 | $29 |
| Biofrontera Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $25 |
Products named: UBRELVY, EVENITY, OTEZLA, Ozempic, QULIPTA, Wegovy, NURTEC ODT, MOUNJARO.
Industry payments across HI — which companies pay providers there.
